Pharma & Healthcare
Roland Berger advises pharma, MedTech and insurance companies on how to master the challenges of the future.
ESG is evolving from a compliance requirement to a strategic advantage, especially in an industry focused on safety and innovation like MedTech. In this episode, our experts Thilo Kaltenbach and Marina Gilic explore why ESG is becoming increasingly relevant and how it is reshaping the industry. MedTech companies are not only adapting to new regulatory frameworks but also using ESG to drive innovation and gain a competitive edge in a market that places growing importance on sustainability.
In this podcast episode, we examine the key trends shaping ESG in MedTech, the drivers behind this shift, and how companies are adjusting to meet rising expectations. As global regulations expand and stakeholders demand greater accountability, ESG is no longer just a compliance issue. It has become a way to strengthen reputation, attract investment, and create new market opportunities.
From reducing emissions and adopting sustainable materials to improving healthcare access and corporate governance, MedTech companies are responding to new ESG challenges. While navigating complex regulations remains a hurdle, industry leaders are already leveraging ESG to enhance efficiency, secure green financing, and attract top talent. With healthcare responsible for approximately 5% of global carbon emissions, MedTech plays a crucial role in sustainable transformation. What does this mean for the future of healthcare innovation?
Listen to this episode on
Spotify
Listen to this episode on
Apple Podcast
Listen to this episode on
Podigee